Showing results (281-290 of 417) with videos related to

Sort By:
Pageof 42
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 14, 2021
Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant RecipientsLauren N Krumeich, Jenna Mancinelli, Andy Cucchiara, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 18, 2006
Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creationMaxim Itkin, Scott O Trerotola, S William Stavropoulos, et al.
Annals of Internal Medicine|April 25, 2015
Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized TrialStefan Zeuzem, Reem Ghalib, K Rajender Reddy, et al.
Hepatology Communications|March 8, 2021
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCCRoniel Cabrera, Amit G Singal, Massimo Colombo, et al.
Hepatology Communications|April 21, 2022
First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamideCalvin Q Pan, Nezam H Afdhal, Victor Ankoma-Sey, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2016
Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of InsuranceVincent Lo Re, Charitha Gowda, Paul N Urick, et al.
The American Journal of Medicine|November 25, 2015
Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease StatusVincent Lo Re, Dean M Carbonari, James D Lewis, et al.
Open Forum Infectious Diseases|February 11, 2022
Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18-49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY)Laura L Hammitt, Dean Quinn, Ewa Janczewska, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 31, 2007
Serum apoptosis markers in acute liver failure: a pilot studyAnna E Rutherford, Linda S Hynan, Carolina B S Borges, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 18, 2022
Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis CohortJasmohan S Bajaj, Puneeta Tandon, Jacqueline G O'Leary, et al.
Pageof 42